Title : Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial.

Pub. Date : 2012 Sep

PMID : 22898678






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We aimed to assess efficacy and safety of vandetanib, a tyrosine kinase inhibitor of RET, VEGFR and EGFR signalling, in this setting. vandetanib kinase insert domain receptor Homo sapiens